Stocks & Investing
Stocks and Investing
Stocks and Investing
Mon, May 13, 2024
[ Mon, May 13th 2024
] - WOPRAI
[ Mon, May 13th 2024
] - WOPRAI
[ Mon, May 13th 2024
] - WOPRAI
[ Mon, May 13th 2024
] - WOPRAI
[ Mon, May 13th 2024
] - WOPRAI
[ Mon, May 13th 2024
] - WOPRAI
[ Mon, May 13th 2024
] - WOPRAI
[ Mon, May 13th 2024
] - WOPRAI
[ Mon, May 13th 2024
] - WOPRAI
[ Mon, May 13th 2024
] - WOPRAI
[ Mon, May 13th 2024
] - WOPRAI
[ Mon, May 13th 2024
] - WOPRAI
[ Mon, May 13th 2024
] - WOPRAI
[ Mon, May 13th 2024
] - WOPRAI
[ Mon, May 13th 2024
] - WOPRAI
[ Mon, May 13th 2024
] - WOPRAI
[ Mon, May 13th 2024
] - WOPRAI
[ Mon, May 13th 2024
] - WOPRAI
[ Mon, May 13th 2024
] - WOPRAI
[ Mon, May 13th 2024
] - WOPRAI
[ Mon, May 13th 2024
] - WOPRAI
[ Mon, May 13th 2024
] - WOPRAI
[ Mon, May 13th 2024
] - WOPRAI
[ Mon, May 13th 2024
] - WOPRAI
[ Mon, May 13th 2024
] - WOPRAI
[ Mon, May 13th 2024
] - WOPRAI
[ Mon, May 13th 2024
] - WOPRAI
[ Mon, May 13th 2024
] - WOPRAI
[ Mon, May 13th 2024
] - WOPRAI
Robert Burns Maintained (YMAB) at Strong Buy with Increased Target to $22 on, May 13th, 2024
Robert Burns of HC Wainwright & Co., Maintained "Y-mAbs Therapeutics, Inc." (YMAB) at Strong Buy with Increased Target from $21 to $22 on, May 13th, 2024.
Robert has made no other calls on YMAB in the last 4 months.
There are 2 other peers that have a rating on YMAB. Out of the 2 peers that are also analyzing YMAB, 0 agree with Robert's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Robert
- Bill Maughan of "Canaccord Genuity" Maintained at Strong Buy with Increased Target to $26 on, Monday, March 4th, 2024
- Etzer Darout of "BMO Capital" Maintained at Buy with Increased Target to $26 on, Monday, March 4th, 2024
